Healthcare Services

Global Muscle Wasting Disorders Market Set for Strong Expansion Reaching $33.49 Billion by 2030 at 13.8% CAGR

April 2, 2026April 2, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Estimated Market Size Of The Muscle Wasting Disorders Market During 2026–2030?

The muscle wasting disorders market size has experienced swift expansion in recent years. This market is projected to expand from $17.49 billion in 2025 to $19.96 billion in 2026, showing a compound annual growth rate (CAGR) of 14.2%. The historical growth can be attributed to factors such as the prevalence of muscular dystrophy and ALS, increased application of physical therapy, a rise in nutritional supplement consumption, the early integration of anti-inflammatory treatments, and the expansion of hospital-based rehabilitation services.

The market for muscle wasting disorders is projected to experience substantial expansion in the coming years. This market is anticipated to reach $33.5 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 13.8%. This expansion throughout the forecast period stems from several factors, including breakthroughs in gene therapy technologies, increasing capital directed towards regenerative medicine, the proliferation of specialized rehabilitation centers, a heightened need for customized treatment strategies, and an intensified emphasis on nutritional support. Key trends anticipated during the forecast period involve the increasing embrace of gene therapy for muscle regeneration, a greater reliance on nutritional and protein supplements, an amplified requirement for physical rehabilitation initiatives, the widening availability of targeted treatments for muscular dystrophy, and a rise in the application of hormonal and anti-inflammatory drugs.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13706&type=smp

Which Economic Or Industry Drivers Are Impacting The Muscle Wasting Disorders Market?

The increasing adoption of a sedentary lifestyle is projected to drive the expansion of the muscle wasting disorders market in the future. A sedentary lifestyle is characterized by an individual being physically inactive, engaging in little to no physical movement or exercise. This inactive behavior can negatively impact muscle function, leading to a decline in muscle strength and endurance, contributing to muscle wasting disorders, and making it more challenging for individuals to maintain their muscle mass and function. For instance, in March 2025, figures from NHS England, a UK-based executive non-departmental public body, revealed that over one-quarter of adults were classified as inactive, while almost one-third of children and young people (30.2 percent) in 2023 participated in less than 30 minutes of daily physical activity. Consequently, the rising adherence to a sedentary lifestyle is fueling the growth of the muscle wasting disorders market.

How Are The Various Segments Of The Muscle Wasting Disorders Market Categorized?

The muscle wasting disorders market covered in this report is segmented –

1) By Treatment Type: Medications, Physical Therapy, Nutritional Therapy, Surgery, Gene Therapy, Other Treatment Types

2) By Disorder Type: Muscular Dystrophy, Amyotrophic Lateral Sclerosis (ALS), Other Disorder Types

3) By End-User: Hospitals, Rehab Centers, Specialty Clinics, Other End-Users

Subsegments:

1) By Medications: Anabolic Steroids, Hormonal Treatments, Anti-Inflammatory Drugs, Immunomodulatory Agents

2) By Physical Therapy: Resistance Training, Stretching Exercises, Aerobic Conditioning, Rehabilitation Programs

3) By Nutritional Therapy: Protein Supplements, Nutritional Counseling, Dietary Modifications, Micronutrient Supplements

4) By Surgery: Surgical Interventions For Muscle Repair, Orthopedic Surgeries, Procedures For Underlying Conditions

5) By Gene Therapy: Gene Replacement Therapy, CRISPR-Based Approaches, RNA Interference Techniques

6) By Other Treatment Types: Complementary Therapies, Psychological Support, Assistive Devices

What Industry Trends Are Redefining The Muscle Wasting Disorders Market?

Leading companies operating within the muscle wasting disorders market are actively developing innovative solutions, such as novel gene therapy, to better support patients affected by these conditions. This novel gene therapy refers to a medical methodology aimed at achieving a therapeutic impact through the manipulation of gene expression or by altering the biological characteristics of living cells. For instance, in June 2023, Sarepta Therapeutics, a US-based biotechnology firm, unveiled Elevidys, which holds the distinction of being the first gene therapy approved by the U.S. Food and Drug Administration (FDA) for treating Duchenne muscular dystrophy (DMD) in pediatric patients aged 4 to 5 years. Elevidys is a recombinant gene therapy specifically designed to deliver a gene into the body that produces a shortened protein containing selected domains of the dystrophin protein found in normal muscle cells. The product is administered through a single intravenous infusion.

Which Major Firms Influence Developments In The Muscle Wasting Disorders Market?

Major companies operating in the muscle wasting disorders market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Roche Holding AG, Novartis AG, Sanofi, GlaxoSmithKline (GSK), Regeneron Pharmaceuticals, Acceleron Pharma Inc., Biogen Inc., Santhera Pharmaceuticals Holding AG, Mitsubishi Tanabe Pharma, Sarepta Therapeutics Inc., PTC Therapeutics Inc., Ionis Pharmaceuticals Inc., Cytokinetics Incorporated, Scholar Rock, Akashi Therapeutics, aTyr Pharma, MyoTherix Inc., Pephexia Therapeutics, Biophytis SA, TNF Pharmaceuticals Inc., Rejuvenate Biomed, Edgewise Therapeutics

Read the full muscle wasting disorders market report here:

https://www.thebusinessresearchcompany.com/report/muscle-wasting-disorders-global-market-report

What Are The Top-Performing Regions Within The Muscle Wasting Disorders Market?

North America was the largest region in the muscle wasting disorder market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the muscle wasting disorders market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Muscle Wasting Disorders Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=13706&type=smp

Browse Through More Reports Similar to the Global Muscle Wasting Disorders Market 2026, By The Business Research Company

Spasmodic Dysphonia Treatment Global Market Report

https://www.thebusinessresearchcompany.com/report/spasmodic-dysphonia-treatment-global-market-report

Muscle Pain Treatment Global Market Report

https://www.thebusinessresearchcompany.com/report/muscle-pain-treatment-global-market-report

Muscle Spasticity Global Market Report

https://www.thebusinessresearchcompany.com/report/muscle-spasticity-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795